ImmuCision Biotherapeutics
About:
ImmuCision Biotherapeutics develops immunotherapy technologies for cancer treatment.
Website: https://www.immucision.com
Description:
ImmuCision Biotherapeutics focuses on the research and clinical development of immune cell-based therapies for human cancer. They are the development of cell-based immunotherapy for human cancer. They utilizes an innovative dendritic cell technology to generate cancer-fighting tumor antigen and natural killer cells.
Total Funding Amount:
$2M
Headquarters Location:
Baltimore, Maryland, United States
Founded Date:
2017-01-01
Founders:
Hua Cheng
Number of Employees:
1-10
Last Funding Date:
2018-09-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai